Investigating risk factors for heart procedures at Beijing Friendship Hospital
Risk Factor for Percutaneous Coronary Intervention in the Beijing Friendship Hospital
Beijing Friendship Hospital · NCT05728580
This study is trying to find out what risk factors might affect patients with heart disease who need a specific heart procedure, to help improve their treatment and care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Beijing Friendship Hospital (other) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT05728580 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify potential risk factors associated with percutaneous coronary intervention (PCI) in patients with coronary heart disease. By stratifying the risk of these patients, the study seeks to uncover the prognostic value of various risk factors to improve treatment strategies. The primary outcomes measured will include major adverse cardiac and cerebrovascular events (MACCE) and all-cause mortality. The findings could lead to enhanced patient care and reduced healthcare costs.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are undergoing PCI for coronary heart disease.
Not a fit: Patients who have experienced failed PCI treatments or are unable to comply with follow-up procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and management strategies for patients undergoing PCI, ultimately enhancing their quality of life.
How similar studies have performed: Other studies have shown success in identifying risk factors related to PCI, suggesting that this approach is both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than or equal to 18 years at the time of admission to the hospital * PCI patients with coronary heart disease: according to the criteria interpreted in the 2011 American Guidelines for Percutaneous Coronary Intervention. The successful diagnostic criteria of PCI: residual stenosis of the treated vessel\<10% (preferably 0%), and the forward flow is TIMI grade 3, there is no dissection that affects the flow, no important side branch occlusion, no visible thrombus and peripheral embolism. Exclusion Criteria: * Patients who failed in PCI treatment; * Current known inability to follow instructions or comply with follow-up procedures.
Where this trial is running
Beijing, Beijing Municipality
- Beijing Friendship Hospital, Capital Medical University — Beijing, Beijing Municipality, China (RECRUITING)
Study contacts
- Study coordinator: Bingbing Ke, Dr
- Email: 1017120710@qq.com
- Phone: 15510286857
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiovascular Diseases, Percutaneous Coronary Intervention, coronary heart disease